spacer
spacer

PDBsum entry 1l7t

Go to PDB code: 
protein Protein-protein interface(s) links
Immune system PDB id
1l7t

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
219 a.a. *
220 a.a. *
Waters ×291
* Residue conservation analysis
PDB id:
1l7t
Name: Immune system
Title: Crystal structure analysis of the anti-testosterone fab fragment
Structure: Anti-testosterone (light chain). Chain: l. Fragment: fab77 fragment. Engineered: yes. Anti-testosterone (heavy chain). Chain: h. Fragment: fab77 fragment. Engineered: yes
Source: Mus musculus. House mouse. Organism_taxid: 10090. Expressed in: escherichia coli. Expression_system_taxid: 562.
Biol. unit: Dimer (from PQS)
Resolution:
2.10Å     R-factor:   0.213     R-free:   0.275
Authors: J.Valjakka,A.Hemminki,S.Niemi,H.Soderlund,K.Takkinen,J.Rouvinen
Key ref:
J.Valjakka et al. (2002). Crystal structure of an in vitro affinity- and specificity-matured anti-testosterone Fab in complex with testosterone. Improved affinity results from small structural changes within the variable domains. J Biol Chem, 277, 44021-44027. PubMed id: 12196551 DOI: 10.1074/jbc.M208392200
Date:
17-Mar-02     Release date:   02-Oct-02    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q65ZC0  (Q65ZC0_MOUSE) -  Kappa light chain C_region (Fragment) from Mus musculus
Seq:
Struc:
219 a.a.
219 a.a.*
Protein chain
Pfam   ArchSchema ?
Q91Z05  (Q91Z05_MOUSE) -  Ighg protein from Mus musculus
Seq:
Struc:
473 a.a.
220 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 82 residue positions (black crosses)

 

 
DOI no: 10.1074/jbc.M208392200 J Biol Chem 277:44021-44027 (2002)
PubMed id: 12196551  
 
 
Crystal structure of an in vitro affinity- and specificity-matured anti-testosterone Fab in complex with testosterone. Improved affinity results from small structural changes within the variable domains.
J.Valjakka, A.Hemminki, S.Niemi, H.Söderlund, K.Takkinen, J.Rouvinen.
 
  ABSTRACT  
 
A highly selective, high affinity recombinant anti-testosterone Fab fragment has been generated by stepwise optimization of the complementarity-determining regions (CDRs) by random mutagenesis and phage display selection of a monoclonal antibody (3-C(4)F(5)). The best mutant (77 Fab) was obtained by evaluating the additivity effects of different independently selected CDR mutations. The 77 Fab contains 20 mutations and has about 40-fold increased affinity (K(d) = 3 x 10(-10) m) when compared with the wild-type (3-C(4)F(5)) Fab. To obtain structural insight into factors, which are needed to improve binding properties, we have determined the crystal structures of the mutant 77 Fab fragment with (2.15 A) and without testosterone (2.10 A) and compared these with previously determined wild-type structures. The overall testosterone binding of the 77 Fab is similar to that of the wild-type. The improved affinity and specificity of the 77 Fab fragment are due to more comprehensive packing of the testosterone with the protein, which is the result of small structural changes within the variable domains. Only one important binding site residue Glu-95 of the heavy chain CDR3 is mutated to alanine in the 77 Fab fragment. This mutation, originally selected from the phage library based on improved specificity, provides more free space for the testosterone D-ring. The light chain CDR1 of 77 Fab containing eight mutations has the most significant effect on the improved affinity, although it has no direct contact with the testosterone. The mutations of CDR-L1 cause a rearrangement in its conformation, leading to an overall fine reshaping of the binding site.
 
  Selected figure(s)  
 
Figure 6.
Fig. 6. Superposition of binding sites of the 77 Fab (top panel) and wt Fab (bottom panel) in the free and testosterone-bound form. The free structures are shown in pink, and testosterone complex is shown in black. Stereopairs were prepared with the Molscript program (29).
Figure 7.
Fig. 7. The binding site in the 77 Fab (A) and in the wt Fab (B) structures. The solvent-accessible surface was produced using the O program (21).
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2002, 277, 44021-44027) copyright 2002.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21360611 M.H.Niemi, K.Takkinen, L.K.Amundsen, H.Söderlund, J.Rouvinen, and M.Höyhtyä (2011).
The testosterone binding mechanism of an antibody derived from a naïve human scFv library.
  J Mol Recognit, 24, 209-219.
PDB code: 3kdm
21152564 N.Kobayashi, and H.Oyama (2011).
Antibody engineering toward high-sensitivity high-throughput immunosensing of small molecules.
  Analyst, 136, 642-651.  
20466534 D.Romanazzo, F.Ricci, G.Volpe, C.T.Elliott, S.Vesco, K.Kroeger, D.Moscone, J.Stroka, H.Van Egmond, M.Vehniäinen, and G.Palleschi (2010).
Development of a recombinant Fab-fragment based electrochemical immunosensor for deoxynivalenol detection in food samples.
  Biosens Bioelectron, 25, 2615-2621.  
19175944 P.Pansri, N.Jaruseranee, K.Rangnoi, P.Kristensen, and M.Yamabhai (2009).
A compact phage display human scFv library for selection of antibodies to a wide variety of antigens.
  BMC Biotechnol, 9, 6.  
18813220 A.Rothe, B.E.Power, and P.J.Hudson (2008).
Therapeutic advances in rheumatology with the use of recombinant proteins.
  Nat Clin Pract Rheumatol, 4, 605-614.  
18574150 R.Barderas, J.Desmet, P.Timmerman, R.Meloen, and J.I.Casal (2008).
Affinity maturation of antibodies assisted by in silico modeling.
  Proc Natl Acad Sci U S A, 105, 9029-9034.  
16553557 S.G.Park, Y.J.Jung, Y.Y.Lee, C.M.Yang, I.J.Kim, J.H.Chung, I.S.Kim, Y.J.Lee, S.J.Park, J.N.Lee, S.K.Seo, Y.H.Park, and I.H.Choi (2006).
Improvement of neutralizing activity of human scFv antibodies against hepatitis B virus binding using CDR3 V(H) mutant library.
  Viral Immunol, 19, 115-123.  
14990736 M.B.Zwick, H.K.Komori, R.L.Stanfield, S.Church, M.Wang, P.W.Parren, R.Kunert, H.Katinger, I.A.Wilson, and D.R.Burton (2004).
The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5.
  J Virol, 78, 3155-3161.  
14732928 R.L.Rich, and D.G.Myszka (2003).
A survey of the year 2002 commercial optical biosensor literature.
  J Mol Recognit, 16, 351-382.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer